Icade SA
PAR:ICAD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.91
35.92
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Icade SA
Icade SA
Net Income (Common)
Icade SA
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Icade SA
PAR:ICAD
|
Net Income (Common)
-€955.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gecina SA
PAR:GFC
|
Net Income (Common)
-€916.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Patrimoine et Commerce SCA
PAR:PAT
|
Net Income (Common)
€31.1m
|
CAGR 3-Years
29%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Immobiliere Dassault SA
PAR:IMDA
|
Net Income (Common)
-€18.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Atland SA
PAR:ATLD
|
Net Income (Common)
€11.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Bleecker SA
PAR:BLEE
|
Net Income (Common)
-€38m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Icade SA
Glance View
In the bustling world of real estate, Icade SA carves out a unique niche as a pivotal player in the French market. Born out of the Caisse des Dépôts conglomerate, Icade is rooted in a tradition of resilience and innovation. The company intricately weaves its operations across three primary areas: property investment, healthcare real estate, and property development. Its property investment arm predominantly deals with office spaces, strategically positioned in major urban hubs like Paris and its environs. This focus allows Icade to benefit from steady rental income, often buoyed by long-term leases to prestigious clients. Meanwhile, its healthcare property segment addresses the ever-growing demand for medical facilities, acquiring and leasing spaces to operators, thereby tapping into a sector that's not only resilient but poised for growth amidst demographic changes. Complementing these robust investments, Icade's property development division injects dynamism into its portfolio. Here, Icade engages in the creation of new residential and commercial properties, harnessing its expertise to meet the evolving architectural and technological needs of modern living and working spaces. This diversification not only provides Icade with direct revenue streams from sales and leasing but also enhances its asset management prowess, increasing its appeal to investors and stakeholders. In essence, Icade’s business model thrives on a balanced interplay between secure, long-term rental income and the lucrative, albeit more volatile, profits from property development. The company’s strategic diversification within the real estate market underscores a commitment to both stability and growth, ensuring that it remains a formidable force in its domain.
See Also
What is Icade SA's Net Income (Common)?
Net Income (Common)
-955.4m
EUR
Based on the financial report for Jun 30, 2024, Icade SA's Net Income (Common) amounts to -955.4m EUR.
What is Icade SA's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-24%
Over the last year, the Net Income (Common) growth was -24%.
You don't have any saved screeners yet
